Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL CHEMIC Gains 3%; BSE HEALTHCARE Index Down 0.0%
Thu, 22 Aug 10:20

HIKAL CHEMIC Gains 3%; BSE HEALTHCARE Index Down 0.0%Image source: Kameleon007 /www.istockphoto.com

HIKAL CHEMIC share price has zoomed 3% and is presently trading at Rs 337.8.

Meanwhile, the BSE HEALTHCARE index is at 41,991.6 .

Among the top gainers in the BSE HEALTHCARE index today are AARTI DRUGS (up 7.6%) and Abbott India (up 3.0%).

GSK Pharma (down 2.9%) and Procter & Gamble Health (down 2.7%) are among the top losers today.

Over the last one year, HIKAL CHEMIC has moved up from Rs 284.3 to Rs 337.8, registering a gain of Rs 53.6 (up 18.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 41,991.6, registering a gain of 49.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.7%), Glenmark Pharma (up 114.8%) and GSK Pharma (up 111.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,030.5 (up 0.2%).

The top gainers among the BSE Sensex today are Bharti Airtel (up 1.2%) and Asian Paints (up 1.0%). The most traded stocks in the BSE Sensex are Bharti Airtel and Tata Steel.

In the meantime, NSE Nifty is at 24,813.8 (up 0.2%). Grasim Industries and Tata Consumer Products are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 81,030.5, registering a gain of 15,814.4 points (up 24.2%).

HIKAL CHEMIC Financial Update...

HIKAL CHEMIC net profit fell 26.1% YoY to Rs 51 million for the quarter ended June 2024, compared to a profit of Rs 69 million a year ago. Net sales rose 4.8% to Rs 4,068 million during the period as against Rs 3,880 million in April-June 2023.

For the year ended March 2023, HIKAL CHEMIC reported 51.2% decrease in net profit to Rs 784 million compared to net profit of Rs 1,605 million during FY22. Revenue of the company grew 4.1% to Rs 20,230 million during FY23.

The current Price to earnings ratio of HIKAL CHEMIC, based on rolling 12 month earnings, stands at 61.5.


Equitymaster requests your view! Post a comment on "HIKAL CHEMIC Gains 3%; BSE HEALTHCARE Index Down 0.0%". Click here!